vs

Side-by-side financial comparison of NATURAL HEALTH TRENDS CORP (NHTC) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

NATURAL HEALTH TRENDS CORP is the larger business by last-quarter revenue ($9.7M vs $5.0M, roughly 1.9× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -6.0%, a 0.4% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -10.1%). NATURAL HEALTH TRENDS CORP produced more free cash flow last quarter ($-964.0K vs $-977.3K). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -5.6%).

Sword Health is a digital health company that develops physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, and injury prevention. The company was founded in 2015 in Portugal by Virgílio Bento and Márcio Colunas. Its services include digital physical therapy with artificial intelligence (AI) integrated into the care model. As of 2024, Sword Health operates internationally, with offices in the United States, Ireland, and Portugal. The company has been valued at $3 bil...

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

NHTC vs YCBD — Head-to-Head

Bigger by revenue
NHTC
NHTC
1.9× larger
NHTC
$9.7M
$5.0M
YCBD
Growing faster (revenue YoY)
YCBD
YCBD
+8.2% gap
YCBD
-1.9%
-10.1%
NHTC
Higher net margin
YCBD
YCBD
0.4% more per $
YCBD
-5.6%
-6.0%
NHTC
More free cash flow
NHTC
NHTC
$13.3K more FCF
NHTC
$-964.0K
$-977.3K
YCBD
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-5.6%
NHTC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NHTC
NHTC
YCBD
YCBD
Revenue
$9.7M
$5.0M
Net Profit
$-588.0K
$-283.1K
Gross Margin
72.9%
59.8%
Operating Margin
-6.5%
-5.7%
Net Margin
-6.0%
-5.6%
Revenue YoY
-10.1%
-1.9%
Net Profit YoY
-434.1%
-1975.7%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NHTC
NHTC
YCBD
YCBD
Q4 25
$9.7M
$5.0M
Q3 25
$9.5M
$4.7M
Q2 25
$9.8M
$4.6M
Q1 25
$10.7M
$4.7M
Q4 24
$10.8M
$5.1M
Q3 24
$10.7M
$4.6M
Q2 24
$10.5M
$5.2M
Q1 24
$11.0M
$4.4M
Net Profit
NHTC
NHTC
YCBD
YCBD
Q4 25
$-588.0K
$-283.1K
Q3 25
$-431.0K
$-680.0K
Q2 25
$15.0K
$-895.3K
Q1 25
$122.0K
$-480.8K
Q4 24
$176.0K
$15.1K
Q3 24
$35.0K
$-152.8K
Q2 24
$173.0K
$459.7K
Q1 24
$188.0K
$-3.0M
Gross Margin
NHTC
NHTC
YCBD
YCBD
Q4 25
72.9%
59.8%
Q3 25
73.7%
58.8%
Q2 25
73.9%
61.5%
Q1 25
73.6%
62.3%
Q4 24
74.2%
66.5%
Q3 24
74.1%
53.9%
Q2 24
74.2%
65.8%
Q1 24
73.4%
59.0%
Operating Margin
NHTC
NHTC
YCBD
YCBD
Q4 25
-6.5%
-5.7%
Q3 25
-5.2%
-14.5%
Q2 25
-3.4%
-19.6%
Q1 25
-3.2%
-10.2%
Q4 24
-3.9%
-1.7%
Q3 24
-2.6%
-6.9%
Q2 24
-2.3%
-7.4%
Q1 24
-3.3%
-35.4%
Net Margin
NHTC
NHTC
YCBD
YCBD
Q4 25
-6.0%
-5.6%
Q3 25
-4.5%
-14.4%
Q2 25
0.2%
-19.4%
Q1 25
1.1%
-10.1%
Q4 24
1.6%
0.3%
Q3 24
0.3%
-3.4%
Q2 24
1.7%
8.9%
Q1 24
1.7%
-68.8%
EPS (diluted)
NHTC
NHTC
YCBD
YCBD
Q4 25
$-0.05
Q3 25
$-0.04
Q2 25
$0.00
Q1 25
$0.01
Q4 24
$0.01
Q3 24
$0.00
Q2 24
$0.02
$-0.15
Q1 24
$0.02
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NHTC
NHTC
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$28.9M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.4M
$9.0M
Total Assets
$38.4M
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NHTC
NHTC
YCBD
YCBD
Q4 25
$28.9M
$3.4M
Q3 25
$32.0M
$2.3M
Q2 25
$34.2M
$1.1M
Q1 25
$41.9M
$1.8M
Q4 24
$43.9M
$2.0M
Q3 24
$46.3M
$2.5M
Q2 24
$48.7M
$2.4M
Q1 24
$54.4M
$2.1M
Stockholders' Equity
NHTC
NHTC
YCBD
YCBD
Q4 25
$23.4M
$9.0M
Q3 25
$26.1M
$7.2M
Q2 25
$28.9M
$6.1M
Q1 25
$30.9M
$665.8K
Q4 24
$32.9M
$1.8M
Q3 24
$35.3M
$2.0M
Q2 24
$37.3M
$3.0M
Q1 24
$39.4M
$3.1M
Total Assets
NHTC
NHTC
YCBD
YCBD
Q4 25
$38.4M
$11.8M
Q3 25
$42.3M
$10.4M
Q2 25
$45.2M
$9.9M
Q1 25
$53.2M
$10.9M
Q4 24
$55.4M
$11.5M
Q3 24
$58.3M
$10.6M
Q2 24
$61.5M
$13.8M
Q1 24
$67.6M
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NHTC
NHTC
YCBD
YCBD
Operating Cash FlowLast quarter
$-959.0K
$-812.5K
Free Cash FlowOCF − Capex
$-964.0K
$-977.3K
FCF MarginFCF / Revenue
-9.9%
-19.5%
Capex IntensityCapex / Revenue
0.1%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.1M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NHTC
NHTC
YCBD
YCBD
Q4 25
$-959.0K
$-812.5K
Q3 25
$113.0K
$-240.7K
Q2 25
$-5.6M
$-704.2K
Q1 25
$484.0K
$-189.5K
Q4 24
$88.0K
$-317.9K
Q3 24
$-436.0K
$167.4K
Q2 24
$-3.6M
$289.8K
Q1 24
$549.0K
$-704.1K
Free Cash Flow
NHTC
NHTC
YCBD
YCBD
Q4 25
$-964.0K
$-977.3K
Q3 25
$70.0K
$-243.6K
Q2 25
$-5.6M
$-705.7K
Q1 25
$468.0K
$-205.0K
Q4 24
$68.0K
$-482.3K
Q3 24
$-443.0K
$157.4K
Q2 24
$-3.6M
Q1 24
$538.0K
$-708.7K
FCF Margin
NHTC
NHTC
YCBD
YCBD
Q4 25
-9.9%
-19.5%
Q3 25
0.7%
-5.2%
Q2 25
-57.5%
-15.3%
Q1 25
4.4%
-4.3%
Q4 24
0.6%
-9.4%
Q3 24
-4.1%
3.5%
Q2 24
-34.2%
Q1 24
4.9%
-16.2%
Capex Intensity
NHTC
NHTC
YCBD
YCBD
Q4 25
0.1%
3.3%
Q3 25
0.5%
0.1%
Q2 25
0.0%
0.0%
Q1 25
0.1%
0.3%
Q4 24
0.2%
3.2%
Q3 24
0.1%
0.2%
Q2 24
0.2%
0.0%
Q1 24
0.1%
0.1%
Cash Conversion
NHTC
NHTC
YCBD
YCBD
Q4 25
Q3 25
Q2 25
-375.67×
Q1 25
3.97×
Q4 24
0.50×
-21.06×
Q3 24
-12.46×
Q2 24
-20.62×
0.63×
Q1 24
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NHTC
NHTC

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons